This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Anne M Morel Montero: Innovator in Eosinophil and Basophil Detection
Introduction
Anne M Morel Montero is a notable inventor based in Marseilles, France. She has made significant contributions to the field of medical diagnostics, particularly in the detection and quantification of eosinophils and basophils. Her innovative approach has the potential to enhance the understanding and treatment of various medical conditions.
Latest Patents
Anne holds a patent for a method that involves contacting a sample, which may contain eosinophils or basophils, with an IL-5 anti-receptor monoclonal antibody. This antibody does not interfere with IL-5 fixation to its receptor and does not inhibit the biological activity of IL-5. This method is crucial for accurately detecting and quantifying these immune cells. The patent is titled "Method for detecting or quantifying basophils and eosinophils" and represents her commitment to advancing medical technology. She has 1 patent to her name.
Career Highlights
Throughout her career, Anne has focused on innovative solutions in the medical field. Her work has been instrumental in developing methods that improve diagnostic accuracy and patient care. She continues to explore new avenues for research and development in her area of expertise.
Collaborations
Anne has collaborated with notable colleagues, including Felix Montero-Julian and Hervé Brailly. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Anne M Morel Montero is a pioneering inventor whose work in eosinophil and basophil detection is making a significant impact in medical diagnostics. Her contributions are paving the way for advancements in understanding immune responses and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile